Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Security class unavailable · CUSIP: 98422T100
Event date: 2024-01-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-24-002001
- Form type
- SC 13G
- Filer
- Octagon Capital Advisors LP
- CIK
- CIK 1839435
- Filed
- Feb 06, 2024
- Reporting period
- Jan 02, 2024
- Description
- Schedule 13G beneficial ownership